[
  {
    "question": "Scenario of mucormycosis with black nasal tx",
    "option_a": "(Amphotericin B) is correct because it is the gold standard for the treatment of mucormycosis. Other antifungal agents such as voriconazole, fluconazole, or echinocandins (like caspofungin) are ineffective against Mucorales and therefore not recommended.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Neuro-infectious",
    "explanation": "Mucormycosis is a rapidly progressive, angioinvasive fungal infection that most commonly affects immunocompromised individuals. The presence of black necrotic tissue in the nasal region is a hallmark of rhinocerebral mucormycosis. Mucorales fungi invade blood vessels, leading to thrombosis, subsequent tissue ischemia, and necrosis. This explains the black necrotic lesions particularly seen in the nasal and sinus regions of affected patients. These infections tend to progress rapidly and require prompt intervention. Clinically, patients with mucormycosis present with black, necrotic lesions in the nasal or sinus areas, often accompanied by facial swelling, pain, and sometimes systemic signs of infection. Recognition of the characteristic black tissue is critical, especially in immunocompromised patients, such as those with poorly controlled diabetes or recent COVID-19 infections. Diagnosis is based on clinical suspicion, radiological findings (CT/MRI), and confirmatory tests such as tissue biopsy with fungal stains and culture. Differential diagnoses include invasive aspergillosis and other necrotizing soft tissue infections, but these can be differentiated by their organism-specific morphology and response to antifungal agents. The first-line treatment for mucormycosis is high-dose liposomal Amphotericin B, as it provides broad-spectrum and fungicidal activity against Mucorales. This is typically combined with surgical debridement of necrotic tissue. If Amphotericin B is contraindicated or poorly tolerated, alternative agents like posaconazole or isavuconazole can be considered as second-line treatments. In pregnancy and lactation, Amphotericin B (especially its liposomal formulation) is generally considered safe (FDA Category B), making it the preferred option. Option A (Amphotericin B) is correct because it is the gold standard for the treatment of mucormycosis. Other antifungal agents such as voriconazole, fluconazole, or echinocandins (like caspofungin) are ineffective against Mucorales and therefore not recommended. \u2022 Rapid identification and treatment of mucormycosis are critical as delays can lead to extensive tissue necrosis and poor outcomes.  \u2022 Liposomal Amphotericin B is preferred due to its improved tolerability and reduced renal toxicity.  \u2022 Early surgical debridement in combination with antifungal therapy greatly improves survival rates. Recent clinical studies and guidelines underscore the critical role of early aggressive therapy with liposomal Amphotericin B. There is ongoing research into combination antifungal therapies and newer agents; however, Amphotericin B remains the cornerstone in treating mucormycosis.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "When to add metronidazole",
    "option_a": "(Mastoiditis) is the correct indication for adding metronidazole as it provides essential anaerobic coverage. The marked answer (B) was incorrect because mastoiditis is the condition where anaerobic coverage is crucial. Other scenarios where metronidazole is not indicated include viral infections or uncomplicated aerobic infections.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Metronidazole is an antimicrobial agent that is highly effective against anaerobic bacteria. Its addition is warranted in infections where anaerobes are suspected to play a significant role, such as in mastoiditis. In mastoiditis, the middle ear infection can extend to the mastoid air cells, and anaerobic bacteria may contribute to the infection, particularly in chronic or complicated cases. The anaerobic environment within the mastoid region supports the growth of these bacteria, necessitating coverage with an agent like metronidazole. Patients with mastoiditis often present with postauricular pain, swelling, and tenderness along with systemic signs of infection (fever, malaise). When anaerobic infection is suspected based on clinical or microbiological evidence, metronidazole is added to broad-spectrum antibiotic regimens to ensure adequate coverage. Diagnosis is confirmed via clinical assessment and imaging studies (typically a CT scan of the temporal bone) that demonstrate mastoid air cell involvement. Differential diagnosis includes uncomplicated otitis media and other ear infections where anaerobic bacteria are not a primary concern. First-line treatment for mastoiditis is typically broad-spectrum intravenous antibiotics that cover both aerobic and anaerobic organisms. When there is a high suspicion or evidence of anaerobic involvement, metronidazole is added. In pregnancy and lactation, metronidazole is considered Category B, meaning that it is generally safe when the benefits outweigh the potential risks. Option A (Mastoiditis) is the correct indication for adding metronidazole as it provides essential anaerobic coverage. The marked answer (B) was incorrect because mastoiditis is the condition where anaerobic coverage is crucial. Other scenarios where metronidazole is not indicated include viral infections or uncomplicated aerobic infections. \u2022 Always consider anaerobic coverage in mastoiditis, especially if the infection is complicated or chronic.  \u2022 Metronidazole is an essential addition for achieving comprehensive antimicrobial coverage in such cases. Recent guidelines and reviews emphasize the importance of including anaerobic coverage in the empirical treatment of mastoiditis to prevent complications and ensure resolution of infection. This recommendation is supported by both clinical outcomes and microbiological data.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Governmental clerk came with meningitis most common organism",
    "option_a": "(Pneumococcal) is correct because epidemiological data show that Streptococcus pneumoniae is the most common cause of bacterial meningitis in the adult population, including working professionals such as a governmental clerk. Option B (Meningococcal) is less common in this age group and usually presents with distinctive features such as rash and is more often encountered in adolescents or outbreak settings.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "In adult community-acquired bacterial meningitis, Streptococcus pneumoniae (pneumococcus) is identified as the most common causative pathogen. The epidemiology of meningitis varies by age group, and in working-age adults, S. pneumoniae is predominant. S. pneumoniae invades the central nervous system, leading to an inflammatory response in the meninges. This causes increased permeability of the blood-brain barrier, cerebral edema, and the classical clinical features of meningitis. The organism\u2019s polysaccharide capsule is a key virulence factor, contributing to its ability to evade immune responses. Patients with pneumococcal meningitis commonly present with fever, headache, neck stiffness, and altered mental status. Unlike meningococcal meningitis, which often presents in younger patients and may include a petechial rash, pneumococcal meningitis predominantly affects adults and is associated with higher morbidity and mortality. The diagnosis is confirmed via lumbar puncture and cerebrospinal fluid (CSF) analysis, which typically reveals a high white cell count (predominantly neutrophils), low glucose, and high protein. Gram staining and culture further help to isolate S. pneumoniae. Differential diagnoses include meningitis caused by Neisseria meningitidis, Listeria monocytogenes (especially in older adults), and viral causes of meningitis. Empirical therapy for suspected bacterial meningitis in adults generally involves a combination of intravenous vancomycin and a third-generation cephalosporin (such as ceftriaxone). In patients older than 50 or immunocompromised individuals, ampicillin may be added to cover Listeria monocytogenes. During pregnancy, these antibiotics are used with consideration of fetal safety; for example, ceftriaxone and ampicillin are generally considered safe in pregnancy, while vancomycin use is reserved for cases where benefits outweigh potential risks. Option A (Pneumococcal) is correct because epidemiological data show that Streptococcus pneumoniae is the most common cause of bacterial meningitis in the adult population, including working professionals such as a governmental clerk. Option B (Meningococcal) is less common in this age group and usually presents with distinctive features such as rash and is more often encountered in adolescents or outbreak settings. \u2022 In adults, always consider S. pneumoniae as the leading cause of community-acquired bacterial meningitis.  \u2022 Early empirical treatment is critical to reduce morbidity and mortality.  \u2022 Vaccination against pneumococcus can significantly lower the incidence of pneumococcal meningitis. Recent guidelines continue to support the predominance of S. pneumoniae in adult bacterial meningitis. There have been significant improvements in outcomes with early aggressive antibiotic therapy, and ongoing research is investigating adjunctive therapies to modulate the inflammatory response in pneumococcal meningitis.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Best tx to prevent post herpetic neuralgia",
    "option_a": "(antiviral therapy) is correct because it directly targets viral replication and hence prevents neuronal damage that predisposes to PHN. Other options such as analgesics only manage pain without affecting viral replication, corticosteroids may reduce inflammation but do not consistently prevent PHN, vaccination is preventive of initial reactivation rather than post",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Neuro-infectious",
    "explanation": "Herpes zoster (shingles) results from reactivation of the varicella zoster virus (VZV) that has been dormant in the dorsal root ganglia. The development of postherpetic neuralgia (PHN) is related to nerve damage caused by the viral replication and subsequent inflammation during the acute phase. The early use of antiviral therapy targets viral replication before irreversible neuronal injury occurs. After reactivation, VZV replicates in the affected sensory ganglia, causing inflammation and direct neuronal damage. The extent of injury correlates with the severity of acute pain and the risk of developing PHN. Antiviral agents (such as acyclovir, valacyclovir, or famciclovir) decrease viral replication, limit the inflammatory cascade, and reduce neuronal damage, which has been supported by several randomized controlled trials and meta-analyses showing reduced incidence of PHN when these agents are started within 72 hours of rash onset. Clinically, patients present with a painful, vesicular rash localized to a dermatomal distribution. When antiviral therapy is initiated early, there is a significant reduction in the severity and duration of the rash and pain, which in turn reduces the likelihood of developing chronic neuropathic pain (PHN). The high-risk population, particularly the elderly, benefits the most from early antiviral intervention. Diagnosis of herpes zoster is clinical, based on the characteristic rash and dermatomal pain. Differential diagnoses include herpes simplex infections and contact dermatitis, but these do not typically lead to PHN. Laboratory confirmation (VZV PCR or direct fluorescent antibody testing) is rarely necessary in straightforward cases. It is critical to differentiate from conditions where antivirals do not play a role, such as bacterial infections that require different antimicrobial therapy. First-line management for acute herpes zoster to prevent PHN is antiviral therapy (acyclovir, valacyclovir, or famciclovir) initiated ideally within 72 hours of rash onset. Adjunct therapies include analgesics and, in some cases, corticosteroids for symptomatic relief, although steroids have not consistently been shown to prevent PHN. In pregnant or lactating women, acyclovir is preferred due to its extensive safety profile, though risk-benefit considerations should be discussed. Second-line management includes pain modulators if PHN develops later. Option A (antiviral therapy) is correct because it directly targets viral replication and hence prevents neuronal damage that predisposes to PHN. Other options such as analgesics only manage pain without affecting viral replication, corticosteroids may reduce inflammation but do not consistently prevent PHN, vaccination is preventive of initial reactivation rather than post-infection complications, and neuropathic pain agents are used for symptomatic management of established PHN. 1. Initiate antiviral therapy within 72 hours of rash onset to maximize benefit. 2. Older patients are at higher risk for developing PHN. 3. Early intervention can mitigate long-term complications. Recent meta-analyses and updated guidelines, including those from the CDC and various neurological associations, reaffirm the benefit of early antiviral initiation in reducing the risk of PHN. Ongoing research is focused on optimizing dosing and possibly combining therapies to further improve outcomes.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Fever meningismus mri showing left temporal hyperintensity",
    "option_a": "is correct: a CSF profile showing RBCs and lymphocytic pleocytosis is characteristic for HSV encephalitis. Other options (such as a CSF profile with neutrophilic pleocytosis or a normal CSF profile) would be more indicative of bacterial meningitis or non",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Neuro-infectious",
    "explanation": "HSV encephalitis is a medical emergency characterized by viral infection of the brain parenchyma, most often affecting the temporal lobes. The combination of fever, meningismus (neck stiffness, photophobia, headache), and specific MRI findings (temporal lobe hyperintensity) is highly suggestive of HSV encephalitis. Herpes simplex virus (HSV) typically gains access to the brain via the olfactory tract or trigeminal nerve, leading to necrotizing inflammation and hemorrhagic changes, particularly in the temporal lobes. The resultant meningeal irritation and parenchymal damage explains the clinical symptoms, including the presence of red blood cells (RBCs) in the cerebrospinal fluid (CSF) due to hemorrhagic necrosis. Patients with HSV encephalitis often present with fever, altered mental status, seizures, and focal neurological deficits. The presence of MRI abnormalities in the temporal lobe along with CSF findings of lymphocytic pleocytosis and RBCs strengthens the diagnosis. This specific CSF profile differentiates HSV encephalitis from other forms of meningitis (e.g., bacterial meningitis with neutrophilic predominance). A lumbar puncture and CSF analysis are essential. The typical CSF profile in HSV encephalitis shows lymphocytic pleocytosis, mildly elevated protein, normal or slightly low glucose levels, and importantly, the presence of RBCs. Differential diagnoses include other viral encephalitides, autoimmune encephalitis, and bacterial meningitis, but the combination of temporal lobe MRI changes and CSF RBCs is distinct for HSV. The mainstay of treatment is high-dose intravenous acyclovir initiated as soon as HSV encephalitis is suspected, even before definitive diagnosis, to reduce morbidity and mortality. In pregnant or lactating women, acyclovir is also recommended given its proven efficacy and relative safety profile. Supportive care, including seizure management and intracranial pressure control, is also critical. Option A is correct: a CSF profile showing RBCs and lymphocytic pleocytosis is characteristic for HSV encephalitis. Other options (such as a CSF profile with neutrophilic pleocytosis or a normal CSF profile) would be more indicative of bacterial meningitis or non-inflammatory processes and do not match the combined clinical and radiologic findings described. 1. Temporal lobe involvement on MRI is a classic sign of HSV encephalitis. 2. Early administration of acyclovir is critical, ideally within 48 hours of symptom onset. 3. The presence of RBCs in the CSF is a unique marker for HSV-induced hemorrhagic necrosis. Current guidelines from infectious disease societies stress the urgency of acyclovir initiation based on clinical suspicion alone. Recent studies confirm that early treatment improves neurological outcomes and survival. Research also continues into adjunctive therapies to minimize long-term neurological deficits.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Male Nurse exposed to pt with meningococcal meningitis what to do",
    "option_a": "(rifampin) is correct because it is the standard prophylactic agent for meningococcal exposure. Immediate vaccination is not used for immediate post",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Neuro-infectious",
    "explanation": "Meningococcal meningitis is a highly contagious and potentially fatal infection caused by Neisseria meningitidis. Healthcare workers and close contacts are at risk of acquiring the infection through respiratory droplets. Prophylactic treatment is essential to eliminate nasopharyngeal carriage and prevent secondary cases. Neisseria meningitidis colonizes the nasopharynx and can invade the bloodstream, leading to meningitis and septicemia. Post-exposure prophylaxis with antibiotics, such as rifampin, targets and eradicates the bacterium from the nasopharyngeal mucosa, thereby interrupting transmission. Exposed individuals, such as healthcare workers, may be asymptomatic carriers. However, the risk of developing invasive disease after exposure necessitates prompt prophylactic therapy. The clinical course of meningococcal infection is rapid, with early signs including fever, headache, and meningismus; hence, preventive measures are paramount. This is a prevention scenario rather than a diagnostic dilemma. The differential in managing exposure includes immediate prophylaxis with antibiotics versus waiting for vaccine-induced immunity, which is not immediate. When evaluating an exposure, guidelines help distinguish between various prophylactic antibiotics (rifampin, ciprofloxacin, or ceftriaxone) based on age, pregnancy status, and contraindications. The first-line treatment for post-exposure prophylaxis is rifampin, which effectively eradicates nasopharyngeal carriage. Alternatives include ciprofloxacin and ceftriaxone based on contraindications and patient-specific factors. For pregnant or lactating women, rifampin is generally considered acceptable if benefits outweigh risks; however, ceftriaxone is sometimes preferred because of its safety profile in pregnancy. Timing is critical\u2014administration should occur as soon as possible after exposure. Option A (rifampin) is correct because it is the standard prophylactic agent for meningococcal exposure. Immediate vaccination is not used for immediate post-exposure prophylaxis as it does not confer immediate immunity and is primarily used for long-term prevention and outbreak control. 1. Post-exposure prophylaxis with rifampin should be administered promptly to healthcare workers exposed to meningococcal meningitis. 2. Always consider alternative agents in pregnant patients or where rifampin is contraindicated. 3. Meningococcal disease progresses rapidly; prophylaxis is essential to prevent secondary cases. Recent guidelines from the CDC and WHO continue to endorse rifampin as the first-line prophylactic agent. Ongoing research compares the efficacy and safety of alternative agents in different populations, including pregnant and lactating women, further refining management protocols.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Patient underwent decompression for chiari 2 weeks ago came with meningitis what is the most common organism",
    "option_a": "(Staphylococcus) is correct because these organisms are the most common cause of postoperative meningitis following neurosurgical interventions. Option B (Pneumococcal) is less common in the postoperative setting, as Streptococcus pneumoniae is primarily implicated in community",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Neuro-infectious",
    "explanation": "Postoperative meningitis, especially following neurosurgical procedures, is most commonly caused by bacteria that originate from the skin flora. The disruption of the sterile field during surgery allows these organisms, particularly staphylococci, to enter the intracranial space. After neurosurgery, the breach in the protective barriers (skin and dura) provides an entry point for skin flora organisms. Staphylococcus aureus and coagulase-negative staphylococci are predominant due to their residency on the skin. Their ability to form biofilms on implants and surgical materials further complicates eradication and increases the risk of infection. Patients presenting with signs of meningitis (fever, headache, neck stiffness) in the postoperative period, particularly within a few weeks of surgery, should be evaluated for staphylococcal infections. The clinical presentation in a postoperative context is distinct from community-acquired meningitis, which is more likely caused by Streptococcus pneumoniae. Diagnosis involves CSF analysis via lumbar puncture and cultures. The CSF profile in postoperative meningitis due to staphylococci typically reveals a predominance of neutrophils, elevated protein, and low glucose. Differential diagnoses include viral encephalitis, nosocomial Gram-negative infections, or even pneumococcal meningitis, but the timing and surgical history heavily favor staphylococcal etiology. Empiric treatment for postoperative meningitis should cover staphylococcal species, usually with vancomycin to address potential methicillin-resistant strains. Adjunctive antibiotics may be added if Gram-negative coverage is deemed necessary based on clinical suspicion or culture results. In pregnant or lactating patients, vancomycin is used when benefits outweigh potential risks; careful monitoring and dose adjustments are necessary as guided by infectious disease consultations. Option A (Staphylococcus) is correct because these organisms are the most common cause of postoperative meningitis following neurosurgical interventions. Option B (Pneumococcal) is less common in the postoperative setting, as Streptococcus pneumoniae is primarily implicated in community-acquired meningitis rather than infections following surgical procedures. 1. Postoperative meningitis is most often due to skin flora, with staphylococci being the leading cause. 2. Early recognition and empiric therapy targeting Gram-positive organisms are crucial in the postoperative period. 3. Biofilm formation on surgical implants complicates management and may require prolonged antibiotic therapy. Recent studies and updated guidelines from neurosurgical and infectious disease societies confirm the predominance of staphylococcal infections in postoperative meningitis. Research continues into novel strategies to disrupt biofilms and improve antibiotic penetration in patients with implant-associated infections.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Scenario suggestive of SSPE, EEG attached showed periodic burst asking what to do next",
    "option_a": "(Brain MRI) is not diagnostic as MRI changes are nonspecific. Option b (Brain biopsy) is invasive and rarely needed given the availability of serological tests. Option c (Measles antibody testing) is correct because it confirms the diagnosis by demonstrating intrathecal antibody production against the measles virus.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "c",
    "subspecialty": "Neuro-infectious",
    "explanation": "Subacute sclerosing panencephalitis (SSPE) is a progressive, fatal neurodegenerative disease that typically appears years after an initial measles infection. It is characterized by cognitive decline, motor abnormalities, and myoclonic jerks with a highly suggestive periodic EEG pattern. SSPE is caused by a persistent mutant measles virus in the central nervous system that provokes a chronic inflammatory reaction. The virus evades complete immune clearance, leading to extensive demyelination and neuronal degeneration. Recent evidence has further elucidated the role of viral persistence and immune-mediated injury in disease progression. Patients with SSPE present with a gradual deterioration in cognitive and motor function, often exhibiting behavioral changes, myoclonus, and seizures. The characteristic EEG \u2013 showing periodic, high-amplitude burst-suppression patterns \u2013 when found alongside clinical suspicion, strongly supports the diagnosis. Diagnosis relies on the combination of clinical features, EEG findings, and confirmatory laboratory tests. The most specific diagnostic test is the detection of elevated measles-specific antibodies (IgG, and occasionally IgM) in the CSF, obtained via lumbar puncture. Differential diagnoses include Creutzfeldt-Jakob disease and other encephalopathies, but these do not demonstrate the same pattern of intrathecal measles antibody production. There is no cure for SSPE; treatment is predominantly supportive. Current guidelines suggest the use of antiviral agents (such as intraventricular interferon-\u03b1 or oral isoprinosine) in an attempt to slow disease progression, although evidence is limited. In pregnant or lactating women, management remains supportive with careful consideration of the safety of any experimental therapies. Option a (Brain MRI) is not diagnostic as MRI changes are nonspecific. Option b (Brain biopsy) is invasive and rarely needed given the availability of serological tests. Option c (Measles antibody testing) is correct because it confirms the diagnosis by demonstrating intrathecal antibody production against the measles virus. 1. SSPE typically has a long latency period, occurring years after the initial measles infection. 2. The periodic burst-suppression EEG pattern is a hallmark finding. 3. CSF measles antibody titers are key to the diagnosis. Recent updates in diagnostic protocols emphasize CSF measles antibody testing for its high sensitivity and specificity. Research is ongoing regarding antiviral and immunomodulatory strategies, but early detection remains critical for any potential therapeutic intervention.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Patient has confusion, lymphadenopathy and flaccid paralysis what is the organism",
    "option_a": "(WNV) is correct because it accounts for the combination of confusion, lymphadenopathy, and flaccid paralysis. Option b (Herpes Simplex Virus) typically presents with focal temporal lobe encephalitis and seizures, and option c (Poliovirus) does not account for the encephalopathy or lymphadenopathy observed.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Neuro-infectious",
    "explanation": "West Nile Virus (WNV) is a mosquito-borne flavivirus that can cause a spectrum of illnesses ranging from mild febrile disease to severe neuroinvasive manifestations such as encephalitis and poliomyelitis-like syndromes. WNV enters the bloodstream via a mosquito bite and may cross the blood-brain barrier to infect the central nervous system. The virus targets neurons, particularly affecting the anterior horn cells, which can result in flaccid paralysis. The inflammatory response induced by the infection contributes to altered mental status and, occasionally, systemic manifestations like lymphadenopathy. The patient\u2019s presentation with confusion (suggestive of encephalopathy), lymphadenopathy, and flaccid paralysis fits the profile of a neuroinvasive WNV infection. While lymphadenopathy is not always prominent, it can occur as part of the systemic viral response. Diagnosis is typically achieved through serologic testing for WNV-specific IgM antibodies in the CSF or serum. Polymerase chain reaction (PCR) can also support the diagnosis. Differential diagnoses include herpes simplex virus encephalitis, which more commonly involves temporal lobe features, and poliovirus infection, which typically does not present with encephalopathy or lymphadenopathy. Management of WNV is largely supportive, focusing on maintaining respiratory and hemodynamic stability. There is no specific antiviral therapy approved; treatment consists of intensive care support for severe cases. In pregnant and lactating patients, supportive care remains the standard since antiviral options are limited and must be weighed against fetal/neonatal safety. Option a (WNV) is correct because it accounts for the combination of confusion, lymphadenopathy, and flaccid paralysis. Option b (Herpes Simplex Virus) typically presents with focal temporal lobe encephalitis and seizures, and option c (Poliovirus) does not account for the encephalopathy or lymphadenopathy observed. 1. WNV can cause a poliomyelitis-like flaccid paralysis due to anterior horn cell involvement. 2. Serologic testing (IgM antibodies) is critical for diagnosis. 3. There is no specific antiviral treatment; management is supportive. Recent epidemiological studies highlight the increasing incidence of WNV neuroinvasive disease, particularly in endemic areas during mosquito season. Current guidelines emphasize preventive measures such as mosquito control and public education, while studies on antiviral therapies continue.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Most common cause of polyradiculopathy, no mention of immune status",
    "option_a": "(CMV) is correct as it is the most common infectious cause of polyradiculopathy in the appropriate clinical setting. Option b (TB) is less likely given its more indolent course and typical involvement through arachnoiditis rather than a direct infectious radiculopathy.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Neuro-infectious",
    "explanation": "Cytomegalovirus (CMV) is a member of the herpesvirus family and is known for causing neurologic complications including polyradiculopathy, especially in immunocompromised individuals, though it can occasionally affect immunocompetent hosts. CMV can directly infect the nerve roots, leading to inflammatory demyelination and neuronal damage. This involvement of multiple nerve roots results in polyradiculopathy. The virus is typically reactivated in immunosuppressed states, and its presence in the central nervous system is best confirmed via CSF polymerase chain reaction (PCR). Patients with CMV polyradiculopathy usually present with an acute or subacute onset of radicular pain, weakness, and diminished reflexes. In contrast, TB-related inflammation is more chronic and associated with systemic and constitutional symptoms, helping differentiate the two conditions. The gold standard for diagnosis is CSF analysis with PCR for CMV DNA. Other potential differentials include tuberculous radiculopathy, Lyme disease, and Guillain-Barr\u00e9 syndrome; however, the rapid presentation and PCR confirmation favor CMV. The treatment of choice is antiviral therapy with agents such as ganciclovir or foscarnet, initiated as early as possible to mitigate neuronal damage. In pregnant or lactating patients, the use of ganciclovir requires caution because of its potential teratogenic effects; consultation with infectious disease experts and careful risk-benefit analysis are crucial. Option a (CMV) is correct as it is the most common infectious cause of polyradiculopathy in the appropriate clinical setting. Option b (TB) is less likely given its more indolent course and typical involvement through arachnoiditis rather than a direct infectious radiculopathy. 1. CMV polyradiculopathy presents with rapid onset radicular pain and weakness. 2. CSF PCR is the diagnostic modality of choice. 3. Prompt initiation of antiviral therapy can improve outcomes. Recent clinical guidelines stress the importance of early diagnosis through CSF PCR testing. Although most data are derived from immunocompromised cohorts, emerging evidence suggests that similar principles may apply to immunocompetent individuals in less common cases.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Poor prognostic for brain abscess",
    "option_a": "(Decreased LOC) is a recognized poor prognostic factor as it reflects significant neurological compromise. Option b (Abscess near CSF spaces) is also associated with a worse prognosis due to the risk of rupture and subsequent ventriculitis or meningitis. Therefore, the correct combined answer should include both a and b.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a, b",
    "subspecialty": "Neuro-infectious",
    "explanation": "Brain abscesses are localized infections within the brain parenchyma that can lead to significant morbidity and mortality. Prognostication relies on identifying clinical and radiological factors that indicate more severe disease. Brain abscesses typically result from localized infection, which leads to a collection of pus surrounded by a capsule. A decreased level of consciousness (LOC) at presentation often signifies extensive parenchymal involvement or raised intracranial pressure, while abscesses in close proximity to CSF spaces are at increased risk of rupture, leading to complications such as ventriculitis or meningitis. A patient presenting with a decreased LOC likely indicates advanced disease with significant mass effect or diffuse cerebral dysfunction. Similarly, abscesses near the ventricles or subarachnoid space are more dangerous due to the possibility of rupture and the spread of infection into the CSF. Diagnosis is based on clinical presentation in conjunction with neuroimaging (contrast-enhanced CT or MRI). Differential diagnoses include neoplastic lesions, hemorrhagic strokes, and demyelinating diseases; however, the presence of a ring-enhancing lesion with surrounding edema in the appropriate clinical context is highly suggestive of a brain abscess. Management follows a tiered approach: first-line therapy includes broad-spectrum intravenous antibiotics tailored to the suspected organism, and surgical drainage is indicated for larger abscesses or those causing mass effect. In cases with poor prognostic indicators, aggressive surgical and medical management is crucial. For pregnant or lactating patients, antibiotic selection must prioritize fetal and neonatal safety, often opting for agents with a well-established safety profile while ensuring effective coverage; neurosurgical interventions are similarly undertaken with multidisciplinary consultation. Option a (Decreased LOC) is a recognized poor prognostic factor as it reflects significant neurological compromise. Option b (Abscess near CSF spaces) is also associated with a worse prognosis due to the risk of rupture and subsequent ventriculitis or meningitis. Therefore, the correct combined answer should include both a and b. 1. A decreased level of consciousness in brain abscess patients is a red flag for severe intracranial pathology. 2. Abscesses adjacent to the CSF spaces carry a higher risk of rupture. 3. Early multidisciplinary intervention is key to optimizing outcomes. Recent studies and guidelines underscore the importance of early intervention in brain abscess management. There is growing evidence that both neurological status at presentation and abscess location are critical determinants of prognosis, leading to recommendations for aggressive early treatment in such cases.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Best way to prevent post herpetic neuralgia due VZV is?",
    "option_a": "Topical lidocaine",
    "option_b": "Antiviral",
    "option_c": "Steroid",
    "option_d": "Anticonvulsant",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Postherpetic neuralgia (PHN) is a painful complication of herpes zoster that results from nerve injury during viral reactivation. The core strategy to reduce the incidence and severity of PHN is to limit viral replication early in the course of shingles. Varicella zoster virus reactivation causes inflammation and damage to the dorsal root ganglia and peripheral nerves. Early antiviral therapy (e.g., acyclovir, valacyclovir, famciclovir) reduces viral replication, thereby minimizing neuronal injury and subsequent neuropathic pain that characterizes PHN. Patients with shingles experience a painful dermatomal rash. Delay in initiating appropriate antiviral therapy can lead to prolonged nerve inflammation and an increased risk of developing chronic neuropathic pain (PHN). Early intervention is therefore critical, especially in older adults. Herpes zoster is primarily a clinical diagnosis based on a unilateral vesicular rash in a dermatomal distribution. Differential diagnoses include herpes simplex infection and other vesiculobullous disorders. Laboratory confirmation (PCR, direct fluorescent antibody) is rarely necessary in routine practice. According to current guidelines, early initiation of antiviral therapy (preferably within 72 hours of rash onset) is the first\u2010line measure to reduce the risk and duration of PHN. Adjunct treatments for established PHN include tricyclic antidepressants, anticonvulsants (gabapentin, pregabalin), and topical agents like lidocaine \u2013 however, these do not prevent the development of PHN. In pregnancy and lactation, acyclovir is considered relatively safe and is used when indicated, although risk versus benefit should be carefully weighed. A: Topical lidocaine is used for symptomatic relief in established PHN but does not prevent its onset. B: Antiviral therapy is the correct answer as early administration reduces viral replication and nerve damage. C: Steroids have been examined but do not have the proven preventive effect for PHN when used alone. D: Anticonvulsants help in treating neuropathic pain but are not preventive. 1. Initiate antiviral therapy within 72 hours of rash onset to decrease PHN risk. 2. Vaccination against VZV in older adults is an important preventive measure. 3. PHN can significantly affect quality of life if not prevented. Recent guidelines and meta-analyses continue to support early antiviral treatment as the mainstay of PHN prevention. Updated studies confirm that reducing viral load early correlates with decreased nerve damage and lower PHN incidence.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "10 years old girl referred with rapid deteriorating school performance and intellectual deficits over a course of few weeks. She also has frequent seizures and unsteady gait. On examination she has ataxia, hyperreflexia and bilateral ongoing planters. EEG shows periodic burst of high voltage slow waves followed by recurrent low voltage stretches. Sometimes she is worsening clinically with on-off lethargic state. Brain MRI shows large areas of T signal diffuse cortical/subcortical process. What is the most likely diagnosis?",
    "option_a": "PML",
    "option_b": "SSPE",
    "option_c": "CJD",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Subacute sclerosing panencephalitis (SSPE) is a progressive, fatal encephalitis that occurs years after an initial measles infection. It classically presents in children and adolescents with cognitive decline, behavioral changes, and myoclonic seizures. SSPE is caused by a persistent mutated measles virus infection within the central nervous system. The virus triggers chronic inflammation, demyelination, and progressive neuronal degeneration. Characteristic EEG findings of periodic high\u2010voltage slow wave bursts mirror the widespread cerebral involvement. In this 10\u2010year\u2010old girl, the rapid decline in school performance, seizures, ataxia, and upper motor neuron signs (hyperreflexia, extensor plantar responses) align with SSPE. The hallmark periodic EEG complexes further support the diagnosis, and the MRI findings of diffuse cortical/subcortical involvement are consistent with advanced disease. Diagnosis is based on clinical history, characteristic EEG patterns (periodic complexes), and elevated anti-measles antibody titers in the CSF and serum. Differential diagnoses include progressive multifocal leukoencephalopathy (PML) and Creutzfeldt-Jakob disease (CJD), which have distinct clinical and electrophysiological patterns. There is no cure for SSPE, and treatment is largely supportive. Some regimens have included antiviral agents (e.g., intraventricular interferon-alpha, oral isoprinosine) but with limited success. Management focuses on symptom control and supportive care. In pregnancy and lactation, no specific therapy exists, and management remains symptomatic and supportive to protect both mother and child. A: PML typically occurs in immunocompromised individuals and presents with different imaging and clinical features. B: SSPE is the correct answer, given the age, progression, and distinct EEG findings. C: CJD usually occurs in older patients, progresses more rapidly, and has a different EEG pattern (periodic sharp waves, but with a shorter duration and faster progression). D: The absence of specific details for a fourth option makes it irrelevant. 1. SSPE is a delayed, fatal complication of measles infection \u2013 vaccination is key for prevention. 2. Periodic, stereotyped EEG patterns are highly characteristic of SSPE. 3. Early measles infection increases the risk of SSPE later in life. Recent research has focused on immunomodulatory therapies and antiviral combinations, though none has definitively altered the course of SSPE. Updated measles vaccination programs remain the cornerstone of SSPE prevention.",
    "exam_year": "2022",
    "exam_type": "Part I",
    "image_url": "page_13.png"
  },
  {
    "question": "Patient came with 1 month history fever, headache, + thirst, personality changes. Brain MRI: bilateral cortical/subcortical hypodensities on T2 involving frontal, parietal, occipital, hypothalamus, midbrain, pons, medulla. CSF WBC less than 20 for which 99% are lymphocytes. \u2191 CSF protein, borderline low CSF glucose. DX?",
    "option_a": "TB",
    "option_b": "sarcoidosis",
    "option_c": "cryptococcosis",
    "option_d": "bacterial meningitis",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Tuberculous (TB) meningitis is a severe form of extrapulmonary tuberculosis that results from hematogenous spread of Mycobacterium tuberculosis to the central nervous system. It is a subacute process that can produce widespread meningeal inflammation and parenchymal involvement. In TB meningitis, a rich gelatinous exudate forms in the subarachnoid space predominantly at the base of the brain but can also extend to involve adjacent brain parenchyma. This inflammatory process leads to vasculitis, subsequent infarcts, and sometimes direct parenchymal involvement manifesting as cortical or subcortical signal changes on T2-weighted MRI. Hypothalamic involvement can result in endocrine disturbances (such as altered thirst), while the overall inflammatory milieu causes a chronic meningitic picture with lymphocytic pleocytosis, elevated protein, and low glucose in CSF. The patient\u2019s one-month history of fever, headache, and personality changes with additional symptoms of thirst (suggesting possible hypothalamic involvement) fits the subacute presentation of TB meningitis. Although TB meningitis classically presents with basal meningeal enhancement, parenchymal involvement is not unheard of. The CSF profile \u2013 lymphocyte predominance with low WBC count (which can be low early or in partially treated TB), increased protein, and borderline low glucose \u2013 is typical of TB meningitis. Diagnosis is based on CSF analysis (showing a lymphocytic pleocytosis, high protein, low glucose), neuroimaging (often basal meningeal enhancement, though parenchymal lesions may be seen), and microbiological tests such as acid-fast bacilli smear, culture, or nucleic acid amplification tests (e.g., GeneXpert MTB/RIF). Differential diagnoses include neurosarcoidosis (usually less associated with fever and a more indolent course), cryptococcal meningitis (more common in immunocompromised hosts), and partially treated bacterial meningitis. First-line management consists of antitubercular therapy (ATT) with a four-drug regimen (isoniazid, rifampin, pyrazinamide, and ethambutol) for an extended duration (9-12 months), along with adjunctive corticosteroids (e.g., dexamethasone) to reduce inflammatory complications and improve outcomes. In pregnant or lactating women, first-line anti-TB drugs (except possibly streptomycin, which is contraindicated) are considered safe and should be used following established guidelines. A: TB \u2013 This is the correct answer given the clinical presentation (fever, headache, personality changes, and hypothalamic involvement) and CSF findings (low WBC with lymphocytic predominance, high protein, low glucose). B: Sarcoidosis typically has an insidious onset, is less likely to present with prolonged fever, and is often associated with systemic features like pulmonary involvement. C: Cryptococcosis usually presents in immunocompromised patients and has distinct imaging findings such as gelatinous pseudocysts in the basal ganglia. D: Bacterial meningitis would show a neutrophilic predominance on CSF analysis and usually presents acutely. 1. TB meningitis is a neurologic emergency with high morbidity and mortality if not treated early. 2. The CSF profile in TB meningitis \u2013 lymphocytic pleocytosis, high protein, and low glucose \u2013 is a diagnostic clue. 3. Adjunct corticosteroid use has been shown to improve outcomes in TB meningitis. Recent studies emphasize early diagnosis using rapid molecular tests on CSF and support the use of adjunctive corticosteroids. Guidelines continue to recommend a prolonged course of ATT and careful monitoring for neurological complications.",
    "exam_year": "2022",
    "exam_type": "Part I",
    "image_url": "page_9.png"
  },
  {
    "question": "Sickler boy with back osteomyelitis and epidural abscess, organism?",
    "option_a": "Haemophilus influenzae",
    "option_b": "TB",
    "option_c": "Staph aureus",
    "option_d": "Pseudomonas",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuro-infectious",
    "explanation": "In patients with sickle cell disease, especially children, the risk of osteomyelitis is increased due to functional asplenia and micro-infarctions in bone. Although Salmonella species are classically taught as a common cause of osteomyelitis in sicklers, Staphylococcus aureus remains a predominant pathogen overall\u2014especially in cases involving the vertebral column and epidural abscesses. Sickle cell disease predisposes to vaso-occlusive events that cause bone infarction and necrosis, creating an environment susceptible to infection. While Salmonella may have an enhanced ability to infect these infarcted areas in long bones, Staph aureus is the most common organism isolated in osteomyelitis and is particularly associated with epidural abscess formation due to its virulence and propensity for hematogenous spread. A sickle cell patient presenting with back pain, signs of osteomyelitis, and an epidural abscess should raise concern for a staphylococcal infection. Epidural abscesses require urgent treatment due to the risk of spinal cord compression and potential irreversible neurological damage. Diagnosis involves imaging studies like MRI to identify bony involvement and to detect an epidural abscess, along with obtaining blood cultures and, when possible, aspirate cultures to isolate the organism. Differential diagnoses include Salmonella osteomyelitis (more common in long bones of sickle cell patients), tuberculosis (especially in endemic areas), and, less commonly, Pseudomonas, which is seen in other patient populations such as intravenous drug users. The management of vertebral osteomyelitis and epidural abscess involves prompt broad-spectrum intravenous antibiotics (with coverage for Staph aureus as the primary target) and often surgical drainage/decompression, especially if there is neurological compromise. For sickle cell patients, antibiotic choices must consider both the risk of Salmonella and Staph aureus. In pediatric patients, dosing adjustments are necessary; in pregnant or lactating patients (though not applicable in a boy), safe antibiotics such as certain beta-lactams would be preferred based on susceptibility and safety profiles. A: Haemophilus influenzae is not typically associated with osteomyelitis in this setting. B: TB is an uncommon cause in children with sickle cell disease presenting with an epidural abscess. C: Staph aureus is the correct answer given its known association with both osteomyelitis and epidural abscess, especially in the spine. D: Pseudomonas is more common in other groups (e.g., IV drug users) and is not the leading cause in sickle cell patients. 1. Despite classic teaching regarding Salmonella, S. aureus remains a common cause of osteomyelitis in sickle cell patients, particularly in spinal involvement. 2. Epidural abscess formation is a neurosurgical emergency requiring prompt intervention. 3. Imaging (MRI) is the modality of choice for diagnosing vertebral osteomyelitis and epidural abscess. Recent literature and clinical studies continue to support Staph aureus as the predominant pathogen in vertebral osteomyelitis and epidural abscess across populations, including those with sickle cell disease. Updated management algorithms emphasize early surgical consultation and targeted antibiotic therapy based on culture results.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "What is the cardinal antibiotic in treating neurobrucellosis?",
    "option_a": "Ceftriaxone",
    "option_b": "Doxycycline",
    "option_c": "Vancomycin",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Neurobrucellosis is an infection of the central nervous system caused by Brucella species, typically Brucella melitensis. It is a complication of systemic brucellosis and may manifest as meningitis, encephalitis, myeloradiculitis, or a combination of these. The treatment fundamentally hinges on eradicating the organism with appropriate antibiotics that can penetrate the blood\u2010brain barrier. Brucella organisms are facultative intracellular bacteria that can survive within macrophages. They gain access to the CNS by crossing the blood\u2013brain barrier, leading to inflammation and formation of granulomatous lesions. Although various antibiotics have activity against Brucella, effective treatment of neurobrucellosis demands agents that achieve sustained therapeutic concentrations in the cerebrospinal fluid. Patients with neurobrucellosis may present with a range of neurological symptoms including headache, fever, altered mental status, focal neurological deficits, and signs of meningeal irritation. The chronic nature of the infection and its ability to mimic other CNS disorders make timely and accurate diagnosis critical. Diagnosis involves a combination of clinical suspicion, serologic tests (e.g., standard agglutination test, ELISA), blood cultures, and CSF analysis showing lymphocytic pleocytosis with elevated protein. Differential diagnoses include tuberculous meningitis, neurosarcoidosis, and other chronic CNS infections. According to the latest guidelines, neurobrucellosis is treated using a combination regimen. First-line therapy typically includes doxycycline given for an extended duration (usually several months) along with rifampin. An agent such as ceftriaxone is often added as a third drug to ensure adequate CNS penetration. Pregnancy and lactation considerations are critical since doxycycline (a tetracycline) is contraindicated in pregnancy due to the risk of permanent tooth discoloration and bone growth inhibition. In pregnant or lactating women, alternative regimens (such as trimethoprim-sulfamethoxazole in combination with rifampin, with careful timing to avoid first-trimester exposure) may be considered. Option A (Ceftriaxone) is frequently used as an adjunct for its excellent CSF penetration but is not considered the backbone of therapy. Option C (Vancomycin) does not have proven efficacy against Brucella and is not used in this context. Option B (Doxycycline) is the cardinal antibiotic in treating systemic and neurobrucellosis because it is bacteriostatic against Brucella and, despite its moderate CSF penetration, its long half-life and efficacy in combination regimens make it the cornerstone of treatment. \u2022 Doxycycline remains the backbone of brucellosis management. \u2022 Combination therapy (often with rifampin and ceftriaxone) is required for effective treatment of neurobrucellosis. \u2022 Treatment is prolonged (often several months) to reduce relapse risk. Recent research and guideline updates continue to advocate for a combination approach in neurobrucellosis, emphasizing the need for long-term therapy. Studies have demonstrated that regimens incorporating doxycycline are associated with better outcomes, and there is ongoing evaluation regarding the optimal duration and drug combinations to minimize complications and relapses.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "What is the worst prognostic factor in brain abscess?",
    "option_a": "Location near ventricle",
    "option_b": "Low GCS at time of therapy initiation",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Neurobrucellosis is an infection of the central nervous system caused by Brucella species, typically Brucella melitensis. It is a complication of systemic brucellosis and may manifest as meningitis, encephalitis, myeloradiculitis, or a combination of these. The treatment fundamentally hinges on eradicating the organism with appropriate antibiotics that can penetrate the blood\u2010brain barrier. Brucella organisms are facultative intracellular bacteria that can survive within macrophages. They gain access to the CNS by crossing the blood\u2013brain barrier, leading to inflammation and formation of granulomatous lesions. Although various antibiotics have activity against Brucella, effective treatment of neurobrucellosis demands agents that achieve sustained therapeutic concentrations in the cerebrospinal fluid. Patients with neurobrucellosis may present with a range of neurological symptoms including headache, fever, altered mental status, focal neurological deficits, and signs of meningeal irritation. The chronic nature of the infection and its ability to mimic other CNS disorders make timely and accurate diagnosis critical. Diagnosis involves a combination of clinical suspicion, serologic tests (e.g., standard agglutination test, ELISA), blood cultures, and CSF analysis showing lymphocytic pleocytosis with elevated protein. Differential diagnoses include tuberculous meningitis, neurosarcoidosis, and other chronic CNS infections. According to the latest guidelines, neurobrucellosis is treated using a combination regimen. First-line therapy typically includes doxycycline given for an extended duration (usually several months) along with rifampin. An agent such as ceftriaxone is often added as a third drug to ensure adequate CNS penetration. Pregnancy and lactation considerations are critical since doxycycline (a tetracycline) is contraindicated in pregnancy due to the risk of permanent tooth discoloration and bone growth inhibition. In pregnant or lactating women, alternative regimens (such as trimethoprim-sulfamethoxazole in combination with rifampin, with careful timing to avoid first-trimester exposure) may be considered. Option A (Ceftriaxone) is frequently used as an adjunct for its excellent CSF penetration but is not considered the backbone of therapy. Option C (Vancomycin) does not have proven efficacy against Brucella and is not used in this context. Option B (Doxycycline) is the cardinal antibiotic in treating systemic and neurobrucellosis because it is bacteriostatic against Brucella and, despite its moderate CSF penetration, its long half-life and efficacy in combination regimens make it the cornerstone of treatment. \u2022 Doxycycline remains the backbone of brucellosis management. \u2022 Combination therapy (often with rifampin and ceftriaxone) is required for effective treatment of neurobrucellosis. \u2022 Treatment is prolonged (often several months) to reduce relapse risk. Recent research and guideline updates continue to advocate for a combination approach in neurobrucellosis, emphasizing the need for long-term therapy. Studies have demonstrated that regimens incorporating doxycycline are associated with better outcomes, and there is ongoing evaluation regarding the optimal duration and drug combinations to minimize complications and relapses.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "10- or 12-year-old female brought by her family for the complaint of progressive decline in school performance and abnormal behavior. Her family brought her to psychiatrist that prescribed to her antipsychotic. After that her condition worsened and she became unresponsive. EEG showed periodic burst. MRI brain showed large areas of a signal (diffuse cortical/subcortical) process. Which of the following is the most likely diagnosis?",
    "option_a": "Neuroleptic malignant syndrome",
    "option_b": "Creutzfeldt-Jakob disease (CJD)",
    "option_c": "Subacute sclerosis panencephalitis (SSPE)",
    "option_d": "Progressive multifocal leukoencephalopathy",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuro-infectious",
    "explanation": "Neurobrucellosis is an infection of the central nervous system caused by Brucella species, typically Brucella melitensis. It is a complication of systemic brucellosis and may manifest as meningitis, encephalitis, myeloradiculitis, or a combination of these. The treatment fundamentally hinges on eradicating the organism with appropriate antibiotics that can penetrate the blood\u2010brain barrier. Brucella organisms are facultative intracellular bacteria that can survive within macrophages. They gain access to the CNS by crossing the blood\u2013brain barrier, leading to inflammation and formation of granulomatous lesions. Although various antibiotics have activity against Brucella, effective treatment of neurobrucellosis demands agents that achieve sustained therapeutic concentrations in the cerebrospinal fluid. Patients with neurobrucellosis may present with a range of neurological symptoms including headache, fever, altered mental status, focal neurological deficits, and signs of meningeal irritation. The chronic nature of the infection and its ability to mimic other CNS disorders make timely and accurate diagnosis critical. Diagnosis involves a combination of clinical suspicion, serologic tests (e.g., standard agglutination test, ELISA), blood cultures, and CSF analysis showing lymphocytic pleocytosis with elevated protein. Differential diagnoses include tuberculous meningitis, neurosarcoidosis, and other chronic CNS infections. According to the latest guidelines, neurobrucellosis is treated using a combination regimen. First-line therapy typically includes doxycycline given for an extended duration (usually several months) along with rifampin. An agent such as ceftriaxone is often added as a third drug to ensure adequate CNS penetration. Pregnancy and lactation considerations are critical since doxycycline (a tetracycline) is contraindicated in pregnancy due to the risk of permanent tooth discoloration and bone growth inhibition. In pregnant or lactating women, alternative regimens (such as trimethoprim-sulfamethoxazole in combination with rifampin, with careful timing to avoid first-trimester exposure) may be considered. Option A (Ceftriaxone) is frequently used as an adjunct for its excellent CSF penetration but is not considered the backbone of therapy. Option C (Vancomycin) does not have proven efficacy against Brucella and is not used in this context. Option B (Doxycycline) is the cardinal antibiotic in treating systemic and neurobrucellosis because it is bacteriostatic against Brucella and, despite its moderate CSF penetration, its long half-life and efficacy in combination regimens make it the cornerstone of treatment. \u2022 Doxycycline remains the backbone of brucellosis management. \u2022 Combination therapy (often with rifampin and ceftriaxone) is required for effective treatment of neurobrucellosis. \u2022 Treatment is prolonged (often several months) to reduce relapse risk. Recent research and guideline updates continue to advocate for a combination approach in neurobrucellosis, emphasizing the need for long-term therapy. Studies have demonstrated that regimens incorporating doxycycline are associated with better outcomes, and there is ongoing evaluation regarding the optimal duration and drug combinations to minimize complications and relapses.",
    "exam_year": "2023",
    "exam_type": "Part I"
  },
  {
    "question": "Which of the following infections more common to cause internuclear ophthalmoplegia (INO)?",
    "option_a": "Tuberculosis",
    "option_b": "HIV",
    "option_c": "Cysticercosis",
    "option_d": "Syphilis",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Neuro-infectious",
    "explanation": "Neurobrucellosis is an infection of the central nervous system caused by Brucella species, typically Brucella melitensis. It is a complication of systemic brucellosis and may manifest as meningitis, encephalitis, myeloradiculitis, or a combination of these. The treatment fundamentally hinges on eradicating the organism with appropriate antibiotics that can penetrate the blood\u2010brain barrier. Brucella organisms are facultative intracellular bacteria that can survive within macrophages. They gain access to the CNS by crossing the blood\u2013brain barrier, leading to inflammation and formation of granulomatous lesions. Although various antibiotics have activity against Brucella, effective treatment of neurobrucellosis demands agents that achieve sustained therapeutic concentrations in the cerebrospinal fluid. Patients with neurobrucellosis may present with a range of neurological symptoms including headache, fever, altered mental status, focal neurological deficits, and signs of meningeal irritation. The chronic nature of the infection and its ability to mimic other CNS disorders make timely and accurate diagnosis critical. Diagnosis involves a combination of clinical suspicion, serologic tests (e.g., standard agglutination test, ELISA), blood cultures, and CSF analysis showing lymphocytic pleocytosis with elevated protein. Differential diagnoses include tuberculous meningitis, neurosarcoidosis, and other chronic CNS infections. According to the latest guidelines, neurobrucellosis is treated using a combination regimen. First-line therapy typically includes doxycycline given for an extended duration (usually several months) along with rifampin. An agent such as ceftriaxone is often added as a third drug to ensure adequate CNS penetration. Pregnancy and lactation considerations are critical since doxycycline (a tetracycline) is contraindicated in pregnancy due to the risk of permanent tooth discoloration and bone growth inhibition. In pregnant or lactating women, alternative regimens (such as trimethoprim-sulfamethoxazole in combination with rifampin, with careful timing to avoid first-trimester exposure) may be considered. Option A (Ceftriaxone) is frequently used as an adjunct for its excellent CSF penetration but is not considered the backbone of therapy. Option C (Vancomycin) does not have proven efficacy against Brucella and is not used in this context. Option B (Doxycycline) is the cardinal antibiotic in treating systemic and neurobrucellosis because it is bacteriostatic against Brucella and, despite its moderate CSF penetration, its long half-life and efficacy in combination regimens make it the cornerstone of treatment. \u2022 Doxycycline remains the backbone of brucellosis management. \u2022 Combination therapy (often with rifampin and ceftriaxone) is required for effective treatment of neurobrucellosis. \u2022 Treatment is prolonged (often several months) to reduce relapse risk. Recent research and guideline updates continue to advocate for a combination approach in neurobrucellosis, emphasizing the need for long-term therapy. Studies have demonstrated that regimens incorporating doxycycline are associated with better outcomes, and there is ongoing evaluation regarding the optimal duration and drug combinations to minimize complications and relapses.",
    "exam_year": "2023",
    "exam_type": "Part I"
  },
  {
    "question": "Indian patient came with headache. He is known to have epilepsy on medications. CT brain attached. What is the most likely diagnosis?",
    "option_a": "Cysticercosis",
    "option_b": "Toxoplasmosis",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Neurocysticercosis is a parasitic infection of the central nervous system caused by the larval form of Taenia solium (pork tapeworm). It is the most common cause of acquired epilepsy in endemic areas like India. After ingestion of T. solium eggs, the parasite invades the intestinal wall and disseminates hematogenously to the brain. The larvae develop into cysticerci, which can lodge in the parenchyma, ventricles, or subarachnoid space. The immune response to these cysts, particularly when they begin to degenerate, leads to inflammation responsible for seizures and headaches. Recent evidence emphasizes the role of the host\u2019s immune response in disease evolution. Patients typically present with seizures, headaches, focal neurological deficits, or signs of increased intracranial pressure. In patients with a known history of epilepsy residing in endemic areas, neurocysticercosis is a prime suspect when new headaches or seizure recurrences occur. CT imaging often shows cystic lesions with or without calcifications, depending on the stage of the disease. Diagnosis is primarily made by neuroimaging (CT or MRI), which may reveal cystic lesions, ring-enhancing lesions, or calcified nodules. Differential diagnoses include tuberculomas, brain abscesses, metastases, and toxoplasmosis (especially in immunocompromised patients). Serological tests (EITB) can provide supportive evidence. First-line treatment for viable lesions is albendazole (with or without praziquantel), often combined with corticosteroids to reduce inflammation. Antiepileptic drugs should be used to control seizures. For pregnancy and lactation, the use of albendazole is generally deferred in the first trimester unless benefits outweigh potential risks, while steroids and seizure management follow established guidelines with careful risk\u2010benefit analysis. Option A (Cysticercosis) is correct because the patient is from an endemic region, has a history of epilepsy, and the CT scan (assumed from the prompt) likely shows typical lesions. Option B (Toxoplasmosis) is more common in immunocompromised patients (e.g., HIV/AIDS) and is less likely in an immunocompetent Indian patient with a history of epilepsy. 1. Neurocysticercosis is the leading cause of adult-onset epilepsy in endemic countries. 2. CT imaging findings vary based on the stage but may include characteristic scolex identification. 3. Combination therapy with antiparasitic agents and corticosteroids can help reduce inflammation during cyst degeneration. Recent guidelines and studies support the use of albendazole as the first-line agent for neurocysticercosis, with a tailored approach based on lesion load and location. There is also an increasing emphasis on the duration of corticosteroid tapering to minimize inflammatory complications during cyst resolution.",
    "exam_year": "2023",
    "exam_type": "Part I"
  }
]